saxenda glp 1 agonist (liraglutide) for the Treatment of Obesity, US Saxenda© – A New Treatment

Ceriello A, Novials A, Canivell S, La Sala L, Pujadas G, Esposito K, Testa R, Bucciarelli L, Rondinelli M, Genovese S: Simultaneous GLP-1 and insulin administration acutely enhances their vasodilatory, antiinflammatory, and antioxidant action in type 2 diabetes

However, when administered during reperfusion, both GLP-1 (7-36amide) and GLP-1 (9-36amide) improve functional recovery from I/R injury in both WT and GLP-1R KO mice [201]

10.2147/IJN.S479670

DOI: McMurray JJV, Solomon SD, Inzucchi SE, et al

It works by mimicking the GLP-1 hormone, causing your body to produce more insulin, lowering your blood sugar levels, and signaling fullness to your brain

Early evidence suggests that individuals using GLP-1s spend significantly less money at the grocery store, shifting their purchasing habits away from snacks, alcohol, and carbohydrates while also increasing demand for high-protein and nutrient-dense foods (e.g., Roe, 2025